Universal-Beteiligungs- und Servicegesellschaft
IBRX icon

Universal-Beteiligungs- und Servicegesellschaft’s ImmunityBio IBRX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Buy
24,629
+2,725
+12% +$20.6K ﹤0.01% 2013
2026
Q1 		$168K Buy
+21,904
New +$150K ﹤0.01% 2004

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's IBRX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its ImmunityBio (IBRX) stake by 12% in Q2 2026, buying an estimated $20.6K and bringing the position to 24,629 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #2013.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in IBRX in Q1 2026 and has held it in 2 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 24,629 shares of ImmunityBio worth $216K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 2,725 ImmunityBio shares in Q2 2026, an estimated $20.6K.
  • ImmunityBio made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #2013 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in ImmunityBio in Q1 2026 and has held it in 2 quarters since.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.